Dr. Stipanov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
605 Glenwood Dr
Suite 200
Chattanooga, TN 37404Phone+1 423-698-1844Fax+1 423-624-2226
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
University of Tennessee (Nashville)Residency, Internal Medicine, 1993 - 1996
University of Florida College of MedicineClass of 1993
Certifications & Licensure
TN State Medical License 1995 - 2026
GA State Medical License 1999 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012
Publications & Presentations
PubMed
- 48 citationsCombined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck:...John D. Hainsworth, David R. Spigel, F. Anthony Greco, Dianna Shipley, James D. Peyton
Cancer Journal. 2011-09-01 - 4 citationsA phase II trial of oxaliplatin and trastuzumab in the treatment of HER2-positive metastatic breast cancer.Denise A. Yardley, Davey B. Daniel, Michael A. Stipanov, D. Randolph Drosick, Mark Mainwaring
Cancer Investigation. 2010-09-14 - 5 citationsSingle agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium.John D. Hainsworth, A. A. Meluch, Cassie M. Lane, David R. Spigel, Howard A. Burris
Cancer Investigation. 2010-02-16
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
